You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK - SARS-CoV-2 was introduced to Oregon dozens of times between March and July, according to researchers from Oregon Health and Science University (OHSU), the Knight Cancer Institute, and the Oregon National Primate Research Center.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.
Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.
The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.
In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.
The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.
Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion.
CRISPR has developed into a core tool to facilitate genome editing, inspiring transformative ideas in engineering biology.
Numerous companies now offer non-invasive prenatal screening (testing), many on different technology platforms.